Category: Uncategorized
Curaleaf to Report Second Quarter 2021 Financial and Operational Results on Aug 9
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international…
Harvest Converts Exercise Price of Select Warrants to U.S. Dollars
Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the…
Green Thumb to Hold Second Quarter 2021 Earnings Conference Call on August 11, 2021
Green Thumb Industries Inc., a leading national cannabis consumer packaged goods company and owner of…
GH Group, Inc. and Mercer Park Brand Acquisition Corp. Complete de-SPAC Transaction, Creating the Largest Cannabis Brand-Building Platform in California
Creates a Highly Expansive, Fully Integrated Cannabis Business in California, the World’s Largest Cannabis Market…
Harborside Announces Completion of Salinas Cultivation Facility Upgrades
Harborside Inc. (“Harborside” or the “Company”) (CSE: HBOR),(OTCQX: HBORF) a California-focused, vertically integrated cannabis enterprise, today announced that…
Trulieve Completes Acquisition of Marijuana Retail License for Dispensary Location in Worcester, Massachusetts
Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis…
Columbia Care Announces Closing of US$74.5 Million Private Placement Offering of 6.00% Secured Convertible Notes Due 2025
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the…
C21 Investments Announces Q1 Results
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company”), a vertically integrated cannabis…
Red White & Bloom Brands Announces High Times Branded Vapes Available Throughout Michigan
Red White & Bloom Brands Inc. (CSE: RWB and OTCQX: RWBYF) (“RWB” or the “Company”), a…
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug…
Recent Comments